Native-valve endocarditis due to Candida parapsilosis

Interact Cardiovasc Thorac Surg. 2002 Dec;1(2):66-8. doi: 10.1016/s1569-9293(02)00017-8.

Abstract

Candida parapsilosis endocarditis is associated with a high mortality rate. Usually occurring in intravenous-drug abusers and prosthetic valve recipients, native-valve endocarditis is rarely reported. We describe a case of Candida parapsilosis endocarditis involving the aortic and mitral valves, with the patient surviving prompt double-valve replacement with amphotericin B and fluconazole treatment. Five years after the surgery, the patient was still free of recurrent symptoms. Although the results suggests that prompt surgery combined with pre- and postoperative intravenous amphotericin B and 6 months of oral antifungal antibiotic is adequate for such cases, life-long regular follow-up with echocardiography is still required.